Table 2. Variable parameters of blood glucose and clinical outcomes at 3 months.

	mRS>2 at 3month				mRS>2 at 3month
	Model 1	p	Model 2	P	Model 1	p	Model 2	p
BG before IVT	1.003 (0.995–1.001)	0.425	1.003 (0.996–1.011)	0.392	1.007 (0.998–1.016)	0.143	1.006 (0.997–1.016)	0.190
>180 mg/dL	0.962 (0.339–2.731)	0.942	1.032 (0.360–2.960)	0.953	3.131 (1.036–9.463)	0.043	2.901 (0.921–9.139)	0.069
BG after IVT	1.021 (1.010–1.032)	<0.001	1.021 (1.010–1.032)	<0.001	1.015 (1.005–1.025)	0.002	1.014 (1.004–1.025)	0.007
>180 mg/dL	7.341 (1.800–29.935)	0.005	7.133 (1.733–29.366)	0.007	3.128 (1.095–8.935)	0.033	2.629 (0.865–7.988)	0.088
Mean BG	1.019 (1.007–1.032)	0.002	1.019 (1.007–1.032)	0.002	1.017 (1.005–1.030)	0.006	1.016 (1.004–1.029)	0.010
>180 mg/dL	3.409 (0.860–13.514)	0.081	3.443 (0.864–13.714)	0.080	3.987 (1.312–12.119)	0.015	3.391 (1.076–10.684)	0.037
Maximal BG	1.007 (1.000–1.014)	0.045	1.007 (1.000–1.014)	0.047	1.012 (1.003–1.020)	0.008	1.011 (1.002–1.020)	0.017
>180 mg/dL	1.877 (0.831–4.237)	0.130	1.900 (0.839–4.303)	0.124	3.414 (1.376–8.467)	0.008	3.334 (1.292–8.603)	0.013
SD of BG	0.993 (0.974–1.013)	0.500	0.993 (0.974–1.013)	0.481	1.026 (1.002–1.051)	0.036	1.024 (0.998–1.050)	0.067
SD of mean BG	0.025 (0.001–0.804)	0.037	0.022 (0.001–0.716)	0.032	6.874 (0.135–350.653)	0.337	11.739 (0.106–1299.868)	0.305

mRS>2 at 3 month: Model 1 was adjusted by age, NIHSS, and AF. Model 2 was adjusted by variables with p<0.1 (age, AF, NIHSS, and severe WMH).

Death at 3 month: Model 1 was adjusted by age, NIHSS, AF, and SBP; Model 2 was adjusted by variables with P<0.1 (HTN, CAD, smoking, AF, WMH, and SBP).